Related Experiment Video
Updated: Mar 4, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Impact of prehospital antibiotic therapy differs depending on septic shock origin
Romain Jouffroy1,2,3,4,5,6, Vincent Garrouste7, Basile Gilbert8
1LI2RSO, Orléans University Hospital Orléans University, 45100, Orleans, France. romain.jouffroy@gmail.com.
Insights
Prehospital antibiotics for septic shock patients significantly reduced 30-day mortality. Early antibiotic administration by mobile intensive care units (MICUs) is crucial for improving outcomes in severe sepsis cases.
Area of Science:
- Emergency Medicine
- Critical Care Medicine
- Infectious Diseases
Background:
- International guidelines advocate for early sepsis management bundles to decrease mortality.
- Early antibiotic administration is critical, especially for septic shock patients requiring immediate intervention.
- This study investigates the impact of prehospital antibiotics on 30-day mortality in septic shock patients treated by mobile intensive care units (MICUs).
Purpose of the Study:
- To evaluate the association between prehospital antibiotic administration and 30-day mortality in septic shock patients.
- To compare outcomes for patients receiving antibiotics before hospital arrival versus those who did not.
- To analyze the effect of prehospital antibiotics based on the presumed origin of septic shock.
Main Methods:
- Nationwide observational cohort study in France (May 2016 - December 2021).
- Emulated retrospective randomized controlled trial using weighted Cox proportional hazards models.
- Secondary analysis using weighted logistic regression to assess outcomes by septic shock origin.
Main Results:
- Prehospital antibiotic administration was linked to a reduced risk of 30-day mortality (RR=0.64, 95% CI [0.41-0.97]).
- Significant mortality reduction was observed for pulmonary and urinary origins of septic shock.
- The study included 530 patients, with a 30-day mortality rate of 31%.
Conclusions:
- Prehospital antibiotic administration is associated with decreased 30-day mortality in septic shock patients managed by MICUs.
- The effectiveness of prehospital antibiotics varies depending on the septic shock's origin.
- Further prospective studies are needed to confirm these findings and explore the full benefits of prehospital care bundles.
Background:
International guidelines recommend early a bundle of care to reduce sepsis mortality. Among bundle of care, antibiotic therapy is all the additionally effective when early initiated, especially for the sicker patients, i.e., those with septic shock, for whom it should be started within the first hour. This study aims to examine the impact of prehospital antibiotics administration on 30-day mortality in patients with septic shock, as defined by Sepsis-2, cared for by a prehospital mobile intensive care unit (MICU).
Methods:
We performed a nationwide observational cohort study in France using data from May 2016 to December 2021 including septic shock patients admitted to ICU after receiving prehospital care from a MICU. An emulate retrospective randomized controlled trial using a weighted Cox proportional hazards model was conducted to compare the efficacy of prehospital antibiotic administration versus no prehospital antibiotic administration on 30-day mortality. A secondary analysis assessed the association between prehospital antibiotic administration and 30-day mortality according to presumed septic shock origin.
Results:
Among the 530 patients analyzed, 341 (64%) were males and the mean age was 70 ± 15 years. The 30-day mortality was 31%. The presumed origins of sepsis in the prehospital setting were primarily pulmonary, digestive, and urinary, with respective percentages of 43%, 25%, and 17%, respectively. One-hundred and thirty-two patients (25%) received prehospital antibiotic therapy, a 3rd generation cephalosporin for 98 patients (18%). The inverse probability of treatment weighting analysis emulating the target trial revealed that prehospital antibiotic administration was associated with a lower risk of 30-day mortality compared with no prehospital antibiotic administration: RR = 0.64, 95%CI [0.41-0.97]. The weighted logistic regression model showed a significant association between 30-day mortality and prehospital antibiotic administration for pulmonary origin: RRa = 0.80 [0.86-0.93], urinary origin: RRa = 0.89 [0.80-0.98], and unknown origin: RRa = 0.94 [0.86-0.99].
Conclusion:
The prehospital antibiotics administration is associated with a reduced risk of 30-day mortality among patients suffering from septic shock cared for by a prehospital MICU. The prehospital antibiotic treatment effect differs according to septic shock origin. However, prospective studies are necessary to validate these preliminary findings and to assess the supplementary effects of the bundle of care components.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Acute Pyelonephritis II: Diagnostic Studies and Management
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Urine Studies II: Urine Culture and Sensitivity Test
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Antibiotic Selection

